(+)-pilocarpine increases expression EXP 6480464 Pilocarpine results in increased expression of ATP2A2 protein CTD PMID:15288437 (-)-epigallocatechin 3-gallate increases expression ISO RGD:731733 6480464 epigallocatechin gallate results in increased expression of ATP2A2 mRNA CTD PMID:16084531 (R)-lipoic acid multiple interactions ISO RGD:735992 6480464 Thioctic Acid promotes the reaction [Dietary Fats results in decreased expression of ATP2A2 mRNA] CTD PMID:27260466 (R)-noradrenaline affects abundance ISO RGD:735992 6480464 ATP2A2 protein affects the abundance of Norepinephrine CTD PMID:19328205 (R)-noradrenaline decreases expression EXP 6480464 Norepinephrine results in decreased expression of ATP2A2 mRNA CTD PMID:17592507 (S)-amphetamine decreases expression ISO RGD:735992 6480464 Dextroamphetamine results in decreased expression of ATP2A2 mRNA CTD PMID:12558987 1,2-dichloroethane increases expression ISO RGD:735992 6480464 ethylene dichloride results in increased expression of ATP2A2 mRNA CTD PMID:28189721 , PMID:28960355 1,2-dimethylhydrazine multiple interactions ISO RGD:735992 6480464 Folic Acid inhibits the reaction [1, 2-Dimethylhydrazine results in increased expression of ATP2A2 mRNA] CTD PMID:22206623 1,2-dimethylhydrazine increases expression ISO RGD:735992 6480464 1, 2-Dimethylhydrazine results in increased expression of ATP2A2 mRNA CTD PMID:22206623 1-[(2,3,4-trimethoxyphenyl)methyl]piperazine multiple interactions EXP 6480464 Trimetazidine inhibits the reaction [Oxygen deficiency results in decreased expression of ATP2A2 mRNA] CTD PMID:25937560 17alpha-ethynylestradiol affects expression ISO RGD:735992 6480464 Ethinyl Estradiol affects the expression of ATP2A2 mRNA CTD PMID:17555576 17alpha-ethynylestradiol multiple interactions ISO RGD:735992 6480464 [Ethinyl Estradiol co-treated with Streptozocin] results in decreased expression of ATP2A2 mRNA CTD PMID:29935216 2,3',4,4',5-Pentachlorobiphenyl increases expression ISO RGD:735992 6480464 2 more ... CTD PMID:31388691 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:735992 6480464 Tetrachlorodibenzodioxin results in increased expression of ATP2A2 mRNA CTD PMID:19465110 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:731733 6480464 Tetrachlorodibenzodioxin results in increased expression of ATP2A2 mRNA CTD PMID:20106945 , PMID:23152189 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:735992 6480464 Tetrachlorodibenzodioxin affects the expression of ATP2A2 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of ATP2A2 mRNA CTD PMID:21215274 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of ATP2A2 mRNA CTD PMID:22298810 2,4,6-trinitrobenzenesulfonic acid decreases expression EXP 6480464 Trinitrobenzenesulfonic Acid results in decreased expression of ATP2A2 mRNA, Trinitrobenzenesulfonic Acid results in decreased expression of ATP2A2 protein CTD PMID:17131044 2,6-dinitrotoluene affects expression EXP 6480464 2, 6-dinitrotoluene affects the expression of ATP2A2 mRNA CTD PMID:21346803 2-amino-2-deoxy-D-glucopyranose decreases expression ISO RGD:735992 6480464 Glucosamine results in decreased expression of ATP2A2 mRNA CTD PMID:17178593 3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine decreases expression EXP 6480464 Puromycin Aminonucleoside results in decreased expression of ATP2A2 mRNA, Puromycin Aminonucleoside results in decreased expression of ATP2A2 protein CTD PMID:17457379 3,3',5-triiodo-L-thyronine multiple interactions EXP 6480464 THRB protein promotes the reaction [Triiodothyronine results in increased expression of ATP2A2 mRNA], Triiodothyronine inhibits the reaction [Phenylephrine results in decreased expression of ATP2A2 mRNA] CTD PMID:11577024 3,3',5-triiodo-L-thyronine increases expression EXP 6480464 Triiodothyronine results in increased expression of ATP2A2 mRNA CTD PMID:11577024 3-\{1-[3-(dimethylamino)propyl]-1H-indol-3-yl\}-4-(1H-indol-3-yl)-1H-pyrrole-2,5-dione decreases activity EXP 6480464 bisindolylmaleimide I results in decreased activity of ATP2A2 protein CTD PMID:17003265 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:731733 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ATP2A2 mRNA CTD PMID:28628672 3H-1,2-dithiole-3-thione decreases expression EXP 6480464 1, 2-dithiol-3-thione results in decreased expression of ATP2A2 mRNA CTD PMID:19162173 4-amino-2,6-dinitrotoluene affects expression EXP 6480464 4-amino-2, 6-dinitrotoluene affects the expression of ATP2A2 mRNA CTD PMID:21346803 4-hydroxyphenyl retinamide increases expression ISO RGD:735992 6480464 Fenretinide results in increased expression of ATP2A2 mRNA CTD PMID:28973697 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of ATP2A2 mRNA CTD PMID:24780913 acrylamide affects expression EXP 6480464 Acrylamide affects the expression of ATP2A2 mRNA CTD PMID:28959563 aflatoxin B1 decreases expression ISO RGD:735992 6480464 Aflatoxin B1 results in decreased expression of ATP2A2 mRNA CTD PMID:19770486 aflatoxin B1 decreases methylation ISO RGD:731733 6480464 Aflatoxin B1 results in decreased methylation of ATP2A2 gene CTD PMID:27153756 aldehydo-D-glucosamine decreases expression ISO RGD:735992 6480464 Glucosamine results in decreased expression of ATP2A2 mRNA CTD PMID:17178593 all-trans-retinoic acid decreases expression ISO RGD:731733 6480464 Tretinoin results in decreased expression of ATP2A2 mRNA CTD PMID:16054129 alloxan decreases expression EXP 6480464 Alloxan results in decreased expression of ATP2A2 protein CTD PMID:28483572 amiodarone decreases expression EXP 6480464 Amiodarone results in decreased expression of ATP2A2 mRNA CTD PMID:17535870 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of ATP2A2 mRNA CTD PMID:16483693 Aroclor 1254 decreases expression ISO RGD:735992 6480464 Chlorodiphenyl (54% Chlorine) results in decreased expression of ATP2A2 mRNA CTD PMID:23650126 arsenous acid decreases expression ISO RGD:731733 6480464 Arsenic Trioxide results in decreased expression of ATP2A2 mRNA CTD PMID:20458559 astragaloside IV multiple interactions EXP 6480464 astragaloside A inhibits the reaction [Isoproterenol results in decreased expression of and results in decreased activity of ATP2A2 protein], astragaloside A inhibits the reaction [Isoproterenol results in decreased expression of ATP2A2 mRNA] CTD PMID:17509559 atrazine increases expression ISO RGD:731733 6480464 Atrazine results in increased expression of ATP2A2 mRNA CTD PMID:22378314 atrazine multiple interactions ISO RGD:735992 6480464 Lycopene inhibits the reaction [Atrazine affects the expression of ATP2A2 mRNA] CTD PMID:27112537 atrazine affects expression ISO RGD:735992 6480464 Atrazine affects the expression of ATP2A2 mRNA CTD PMID:27112537 benzene increases expression ISO RGD:731733 6480464 Benzene results in increased expression of ATP2A2 mRNA CTD PMID:19162166 benzo[a]pyrene increases expression ISO RGD:731733 6480464 Benzo(a)pyrene results in increased expression of ATP2A2 mRNA CTD PMID:20106945 benzo[a]pyrene multiple interactions ISO RGD:735992 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ATP2A2 mRNA CTD PMID:27858113 benzo[a]pyrene decreases expression ISO RGD:731733 6480464 Benzo(a)pyrene results in decreased expression of ATP2A2 mRNA CTD PMID:26238291 benzo[a]pyrene decreases expression ISO RGD:735992 6480464 Benzo(a)pyrene results in decreased expression of ATP2A2 mRNA CTD PMID:19770486 more ... benzo[a]pyrene diol epoxide I decreases expression ISO RGD:731733 6480464 7 more ... CTD PMID:19150397 benzo[b]fluoranthene decreases expression ISO RGD:735992 6480464 benzo(b)fluoranthene results in decreased expression of ATP2A2 mRNA CTD PMID:26377693 benzo[b]fluoranthene multiple interactions ISO RGD:735992 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ATP2A2 mRNA CTD PMID:27858113 beta-D-glucosamine decreases expression ISO RGD:735992 6480464 Glucosamine results in decreased expression of ATP2A2 mRNA CTD PMID:17178593 bis(2-ethylhexyl) phthalate increases expression EXP 6480464 Diethylhexyl Phthalate results in increased expression of ATP2A2 mRNA CTD PMID:20920545 bisphenol A increases expression ISO RGD:735992 6480464 bisphenol A results in increased expression of ATP2A2 protein CTD PMID:23418087 bisphenol A multiple interactions ISO RGD:735992 6480464 [bisphenol A co-treated with Streptozocin] results in decreased expression of ATP2A2 mRNA CTD PMID:29935216 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of ATP2A2 mRNA CTD PMID:30816183 bisphenol A affects expression ISO RGD:731733 6480464 bisphenol A affects the expression of ATP2A2 mRNA CTD PMID:30903817 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of ATP2A2 mRNA CTD PMID:25181051 bisphenol F multiple interactions ISO RGD:731733 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ATP2A2 mRNA CTD PMID:28628672 Brodifacoum increases expression EXP 6480464 bromfenacoum results in increased expression of ATP2A2 protein CTD PMID:28903499 butan-1-ol multiple interactions ISO RGD:731733 6480464 [[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of ATP2A2 mRNA CTD PMID:29432896 butanal decreases expression ISO RGD:731733 6480464 butyraldehyde results in decreased expression of ATP2A2 mRNA CTD PMID:26079696 cadmium dichloride increases expression ISO RGD:731733 6480464 Cadmium Chloride results in increased expression of ATP2A2 mRNA CTD PMID:26472689 caffeine affects response to substance ISO RGD:735992 6480464 ATP2A2 protein affects the susceptibility to Caffeine CTD PMID:19328205 calcium atom affects abundance ISO RGD:735992 6480464 ATP2A2 protein affects the abundance of Calcium CTD PMID:19328205 calcium atom affects transport EXP 6480464 ATP2A2 protein affects the transport of Calcium CTD PMID:17287366 calcium atom multiple interactions EXP 6480464 [[Phenylephrine results in increased activity of SLC9A1 protein] which results in increased transport of Calcium] which results in increased expression of ATP2A2 protein more ... CTD PMID:16236312 , PMID:19244478 calcium atom multiple interactions ISO RGD:735992 6480464 PPP3R1 gene mutant form inhibits the reaction [ATP2A2 protein affects the transport of Calcium] CTD PMID:19700627 calcium atom affects uptake ISO RGD:735992 6480464 ATP2A2 protein alternative form affects the uptake of Calcium CTD PMID:11679415 calcium atom affects export ISO RGD:735992 6480464 ATP2A2 protein alternative form affects the export of Calcium CTD PMID:11679415 calcium(0) affects abundance ISO RGD:735992 6480464 ATP2A2 protein affects the abundance of Calcium CTD PMID:19328205 calcium(0) affects transport EXP 6480464 ATP2A2 protein affects the transport of Calcium CTD PMID:17287366 calcium(0) multiple interactions EXP 6480464 [[Phenylephrine results in increased activity of SLC9A1 protein] which results in increased transport of Calcium] which results in increased expression of ATP2A2 protein more ... CTD PMID:16236312 , PMID:19244478 calcium(0) multiple interactions ISO RGD:735992 6480464 PPP3R1 gene mutant form inhibits the reaction [ATP2A2 protein affects the transport of Calcium] CTD PMID:19700627 calcium(0) affects uptake ISO RGD:735992 6480464 ATP2A2 protein alternative form affects the uptake of Calcium CTD PMID:11679415 calcium(0) affects export ISO RGD:735992 6480464 ATP2A2 protein alternative form affects the export of Calcium CTD PMID:11679415 candesartan multiple interactions EXP 6480464 candesartan inhibits the reaction [Isoproterenol results in decreased expression of ATP2A2 protein] CTD PMID:16723803 Candesartan cilexetil increases expression EXP 6480464 candesartan cilexetil results in increased expression of ATP2A2 protein CTD PMID:22120037 capsaicin affects metabolic processing EXP 6480464 Capsaicin affects the metabolism of ATP2A2 protein CTD PMID:18037908 capsaicin decreases expression EXP 6480464 Capsaicin results in decreased expression of ATP2A2 protein modified form CTD PMID:18037908 carbon nanotube affects expression ISO RGD:735992 6480464 Nanotubes, Carbon analog affects the expression of ATP2A2 mRNA CTD PMID:25554681 carbon nanotube increases expression ISO RGD:735992 6480464 Nanotubes, Carbon analog results in increased expression of ATP2A2 mRNA, Nanotubes, Carbon results in increased expression of ATP2A2 mRNA CTD PMID:25620056 carbon nanotube decreases expression ISO RGD:735992 6480464 Nanotubes, Carbon results in decreased expression of ATP2A2 mRNA CTD PMID:25554681 carvedilol multiple interactions EXP 6480464 carvedilol inhibits the reaction [Hydrogen Peroxide results in decreased expression of ATP2A2 mRNA], carvedilol inhibits the reaction [Hydrogen Peroxide results in decreased expression of ATP2A2 protein] CTD PMID:15670758 carvedilol increases expression EXP 6480464 carvedilol results in increased expression of ATP2A2 mRNA CTD PMID:15670758 more ... chloropicrin increases expression ISO RGD:731733 6480464 chloropicrin results in increased expression of ATP2A2 mRNA CTD PMID:26352163 choline multiple interactions ISO RGD:735992 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of ATP2A2 gene CTD PMID:20938992 chrysene multiple interactions ISO RGD:735992 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ATP2A2 mRNA CTD PMID:27858113 cilostazol affects expression EXP 6480464 cilostazol affects the expression of ATP2A2 mRNA, cilostazol affects the expression of ATP2A2 protein CTD PMID:18088389 cisplatin decreases expression EXP 6480464 Cisplatin results in decreased expression of ATP2A2 mRNA CTD PMID:22023808 clofibrate decreases expression EXP 6480464 Clofibrate results in decreased expression of ATP2A2 protein CTD PMID:20118634 cobalt dichloride decreases expression ISO RGD:731733 6480464 cobaltous chloride results in decreased expression of ATP2A2 mRNA CTD PMID:19376846 crocidolite asbestos decreases expression ISO RGD:735992 6480464 Asbestos, Crocidolite results in decreased expression of ATP2A2 mRNA CTD PMID:29279043 cyclosporin A decreases expression ISO RGD:731733 6480464 Cyclosporine results in decreased expression of ATP2A2 mRNA CTD PMID:20106945 delta-tocotrienol multiple interactions ISO RGD:735992 6480464 tocotrienol, delta promotes the reaction [Lipopolysaccharides results in increased expression of ATP2A2 mRNA] CTD PMID:22185406 delta-tocotrienol increases expression ISO RGD:735992 6480464 tocotrienol, delta results in increased expression of ATP2A2 mRNA CTD PMID:22185406 Deoxycorticosterone acetate multiple interactions EXP 6480464 [Desoxycorticosterone Acetate co-treated with Sodium Chloride, Dietary] results in decreased expression of ATP2A2 protein, Metformin inhibits the reaction [[Desoxycorticosterone Acetate co-treated with Sodium Chloride, Dietary] results in decreased expression of ATP2A2 protein] CTD PMID:30290168 dexamethasone multiple interactions ISO RGD:735992 6480464 Dexamethasone promotes the reaction [Lipopolysaccharides results in increased expression of ATP2A2 mRNA] CTD PMID:22185406 dexamethasone multiple interactions ISO RGD:731733 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ATP2A2 mRNA CTD PMID:28628672 dexamethasone increases expression ISO RGD:735992 6480464 Dexamethasone results in increased expression of ATP2A2 mRNA CTD PMID:22185406 diarsenic trioxide decreases expression ISO RGD:731733 6480464 Arsenic Trioxide results in decreased expression of ATP2A2 mRNA CTD PMID:20458559 dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of ATP2A2 mRNA CTD PMID:21266533 dicrotophos increases expression ISO RGD:731733 6480464 dicrotophos results in increased expression of ATP2A2 mRNA CTD PMID:28302478 dieldrin decreases expression EXP 6480464 Dieldrin results in decreased expression of ATP2A2 mRNA CTD PMID:23153324 dioxygen multiple interactions EXP 6480464 Trimetazidine inhibits the reaction [Oxygen deficiency results in decreased expression of ATP2A2 mRNA] CTD PMID:25937560 dioxygen decreases expression EXP 6480464 Oxygen deficiency results in decreased expression of ATP2A2 mRNA CTD PMID:25937560 diuron increases expression EXP 6480464 Diuron results in increased expression of ATP2A2 mRNA CTD PMID:21551480 doxorubicin multiple interactions EXP 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Doxorubicin results in decreased expression of ATP2A2 mRNA] more ... CTD PMID:10625299 more ... doxorubicin decreases expression ISO RGD:731733 6480464 Doxorubicin results in decreased expression of ATP2A2 mRNA CTD PMID:29803840 doxorubicin decreases expression ISO RGD:735992 6480464 Doxorubicin results in decreased expression of ATP2A2 protein CTD PMID:23695218 doxorubicin multiple interactions ISO RGD:735992 6480464 resveratrol inhibits the reaction [Doxorubicin results in decreased expression of ATP2A2 protein] CTD PMID:23695218 doxorubicin decreases expression EXP 6480464 Doxorubicin results in decreased expression of ATP2A2 mRNA, Doxorubicin results in decreased expression of ATP2A2 protein CTD PMID:10625299 more ... enzyme inhibitor multiple interactions ISO RGD:731733 6480464 [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of ATP2A2 protein CTD PMID:23301498 ethanol affects splicing ISO RGD:735992 6480464 Ethanol affects the splicing of ATP2A2 mRNA CTD PMID:30319688 ethanol multiple interactions ISO RGD:735992 6480464 Ethanol affects the expression of and affects the splicing of ATP2A2 mRNA CTD PMID:30319688 fenofibrate decreases expression EXP 6480464 Fenofibrate results in decreased expression of ATP2A2 protein CTD PMID:20118634 fluoxetine increases expression EXP 6480464 Fluoxetine results in increased expression of ATP2A2 mRNA CTD PMID:21852994 folic acid multiple interactions ISO RGD:735992 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of ATP2A2 gene more ... CTD PMID:20938992 , PMID:22206623 fructose multiple interactions ISO RGD:735992 6480464 [Fructose co-treated with Dietary Fats] results in decreased expression of ATP2A2 mRNA, troxerutin inhibits the reaction [[Fructose co-treated with Dietary Fats] results in decreased expression of ATP2A2 mRNA] CTD PMID:28916335 furan increases methylation EXP 6480464 furan results in increased methylation of ATP2A2 gene CTD PMID:22079235 genistein multiple interactions EXP 6480464 [Genistein co-treated with Methoxychlor] results in decreased expression of ATP2A2 mRNA CTD PMID:21782745 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of ATP2A2 mRNA CTD PMID:22061828 glafenine increases expression EXP 6480464 Glafenine results in increased expression of ATP2A2 mRNA CTD PMID:24136188 Goe 6976 decreases activity EXP 6480464 Go 6976 results in decreased activity of ATP2A2 protein CTD PMID:17003265 hexadecanoic acid multiple interactions ISO RGD:735992 6480464 ATP2A2 protein promotes the reaction [7 more ... CTD PMID:29414781 hydrogen peroxide affects response to substance ISO RGD:731733 6480464 ATP2A2 protein affects the susceptibility to Hydrogen Peroxide CTD PMID:19201925 hydrogen peroxide decreases expression EXP 6480464 Hydrogen Peroxide results in decreased expression of ATP2A2 mRNA, Hydrogen Peroxide results in decreased expression of ATP2A2 protein CTD PMID:10625299 more ... hydrogen peroxide multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in decreased expression of ATP2A2 protein] more ... CTD PMID:15670758 , PMID:17005195 indinavir multiple interactions ISO RGD:735992 6480464 [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in decreased expression of ATP2A2 mRNA CTD PMID:11706060 indometacin multiple interactions ISO RGD:731733 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ATP2A2 mRNA CTD PMID:28628672 isoprenaline multiple interactions EXP 6480464 astragaloside A inhibits the reaction [Isoproterenol results in decreased expression of and results in decreased activity of ATP2A2 protein] more ... CTD PMID:16723803 , PMID:17509559 isoprenaline decreases expression EXP 6480464 Isoproterenol results in decreased expression of ATP2A2 mRNA, Isoproterenol results in decreased expression of ATP2A2 protein CTD PMID:16723803 , PMID:17509559 L-methionine multiple interactions ISO RGD:735992 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of ATP2A2 gene CTD PMID:20938992 lamivudine multiple interactions ISO RGD:735992 6480464 [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in decreased expression of ATP2A2 mRNA CTD PMID:11706060 leflunomide increases expression ISO RGD:731733 6480464 leflunomide results in increased expression of ATP2A2 mRNA CTD PMID:28988120 lipoic acid multiple interactions ISO RGD:735992 6480464 Thioctic Acid promotes the reaction [Dietary Fats results in decreased expression of ATP2A2 mRNA] CTD PMID:27260466 lipopolysaccharide increases expression ISO RGD:735992 6480464 Lipopolysaccharides results in increased expression of ATP2A2 mRNA CTD PMID:22185406 lipopolysaccharide multiple interactions ISO RGD:735992 6480464 Dexamethasone promotes the reaction [Lipopolysaccharides results in increased expression of ATP2A2 mRNA], tocotrienol, delta promotes the reaction [Lipopolysaccharides results in increased expression of ATP2A2 mRNA] CTD PMID:22185406 lithium atom multiple interactions EXP 6480464 Lithium inhibits the reaction [Methamphetamine results in decreased expression of ATP2A2 mRNA] CTD PMID:19149911 lithium hydride multiple interactions EXP 6480464 Lithium inhibits the reaction [Methamphetamine results in decreased expression of ATP2A2 mRNA] CTD PMID:19149911 lycopene multiple interactions ISO RGD:735992 6480464 Lycopene inhibits the reaction [Atrazine affects the expression of ATP2A2 mRNA] CTD PMID:27112537 metformin multiple interactions EXP 6480464 Metformin inhibits the reaction [[Desoxycorticosterone Acetate co-treated with Sodium Chloride, Dietary] results in decreased expression of ATP2A2 protein] CTD PMID:30290168 methamphetamine multiple interactions EXP 6480464 Lithium inhibits the reaction [Methamphetamine results in decreased expression of ATP2A2 mRNA] CTD PMID:19149911 methamphetamine decreases expression EXP 6480464 Methamphetamine results in decreased expression of ATP2A2 mRNA CTD PMID:19149911 methotrexate increases expression ISO RGD:731733 6480464 Methotrexate results in increased expression of ATP2A2 mRNA CTD PMID:21678067 methoxychlor multiple interactions EXP 6480464 [Genistein co-treated with Methoxychlor] results in decreased expression of ATP2A2 mRNA CTD PMID:21782745 methylseleninic acid increases expression ISO RGD:731733 6480464 methylselenic acid results in increased expression of ATP2A2 mRNA CTD PMID:18548127 metoprolol increases expression EXP 6480464 Metoprolol results in increased expression of ATP2A2 mRNA CTD PMID:16162791 N-acetyl-L-cysteine increases expression ISO RGD:731733 6480464 Acetylcysteine results in increased expression of ATP2A2 mRNA CTD PMID:16084531 N-acetyl-L-cysteine multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [Doxorubicin results in decreased expression of ATP2A2 mRNA], Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in decreased expression of ATP2A2 protein] CTD PMID:10625299 , PMID:17005195 nickel dichloride decreases expression ISO RGD:731733 6480464 nickel chloride results in decreased expression of ATP2A2 mRNA CTD PMID:17312168 ochratoxin A increases expression EXP 6480464 ochratoxin A results in increased expression of ATP2A2 mRNA CTD PMID:16251485 , PMID:22124623 ochratoxin A decreases expression ISO RGD:731733 6480464 ochratoxin A results in decreased expression of ATP2A2 mRNA CTD PMID:19287073 ozone affects response to substance ISO RGD:731733 6480464 ATP2A2 protein affects the susceptibility to Ozone CTD PMID:19201925 paclitaxel increases expression EXP 6480464 Paclitaxel results in increased expression of ATP2A2 mRNA CTD PMID:15585946 paracetamol affects expression ISO RGD:735992 6480464 Acetaminophen affects the expression of ATP2A2 mRNA CTD PMID:17562736 paracetamol decreases expression ISO RGD:731733 6480464 Acetaminophen results in decreased expression of ATP2A2 mRNA CTD PMID:21420995 paraquat multiple interactions ISO RGD:735992 6480464 IGF1 gene mutant form inhibits the reaction [Paraquat results in increased expression of ATP2A2 protein] CTD PMID:17979500 paraquat affects expression EXP 6480464 Paraquat affects the expression of ATP2A2 mRNA CTD PMID:16854511 paraquat increases expression ISO RGD:735992 6480464 Paraquat results in increased expression of ATP2A2 protein CTD PMID:17979500 perfluorooctanoic acid decreases expression EXP 6480464 perfluorooctanoic acid results in decreased expression of ATP2A2 mRNA CTD PMID:19162173 phenobarbital affects expression ISO RGD:735992 6480464 Phenobarbital affects the expression of ATP2A2 mRNA CTD PMID:23091169 phenylephrine decreases expression EXP 6480464 Phenylephrine results in decreased expression of ATP2A2 mRNA, Phenylephrine results in decreased expression of ATP2A2 protein CTD PMID:11577024 more ... phenylephrine affects response to substance EXP 6480464 ATP2A2 protein affects the susceptibility to Phenylephrine CTD PMID:21952229 phenylephrine increases expression EXP 6480464 Phenylephrine results in increased expression of ATP2A2 mRNA CTD PMID:16236312 phenylephrine decreases activity EXP 6480464 Phenylephrine results in decreased activity of ATP2A2 protein CTD PMID:17287366 phenylephrine multiple interactions ISO RGD:735992 6480464 [Phenylephrine co-treated with ADRA1B protein] results in decreased expression of ATP2A2 protein CTD PMID:11499749 phenylephrine multiple interactions EXP 6480464 (+)-JQ1 compound inhibits the reaction [Phenylephrine results in decreased expression of ATP2A2 mRNA] more ... CTD PMID:11577024 more ... phlorizin increases expression ISO RGD:735992 6480464 Phlorhizin results in increased expression of ATP2A2 mRNA CTD PMID:16123366 phorbol 13-acetate 12-myristate multiple interactions EXP 6480464 Tetradecanoylphorbol Acetate inhibits the reaction [Thapsigargin results in increased expression of ATP2A2 mRNA] CTD PMID:19244478 phorbol 13-acetate 12-myristate increases activity EXP 6480464 Tetradecanoylphorbol Acetate results in increased activity of ATP2A2 protein CTD PMID:17003265 phorbol 13-acetate 12-myristate decreases expression EXP 6480464 Tetradecanoylphorbol Acetate results in decreased expression of ATP2A2 mRNA, Tetradecanoylphorbol Acetate results in decreased expression of ATP2A2 protein CTD PMID:19244478 pirinixic acid increases expression ISO RGD:735992 6480464 pirinixic acid results in increased expression of ATP2A2 mRNA CTD PMID:18301758 more ... piroxicam decreases expression ISO RGD:731733 6480464 Piroxicam results in decreased expression of ATP2A2 mRNA CTD PMID:21858171 potassium dichromate decreases expression ISO RGD:731733 6480464 Potassium Dichromate results in decreased expression of ATP2A2 mRNA CTD PMID:11678601 prazosin multiple interactions EXP 6480464 Prazosin inhibits the reaction [Phenylephrine results in decreased expression of ATP2A2 mRNA] CTD PMID:11577024 , PMID:17592507 procymidone decreases expression EXP 6480464 procymidone results in decreased expression of ATP2A2 mRNA CTD PMID:15686871 progesterone increases expression EXP 6480464 Progesterone results in increased expression of ATP2A2 mRNA CTD PMID:20726854 propiconazole increases expression ISO RGD:735992 6480464 propiconazole results in increased expression of ATP2A2 mRNA CTD PMID:21278054 quercetin multiple interactions ISO RGD:735992 6480464 Quercetin promotes the reaction [Dietary Fats results in decreased expression of ATP2A2 mRNA] CTD PMID:27260466 razoxane multiple interactions EXP 6480464 Razoxane inhibits the reaction [Doxorubicin results in decreased expression of ATP2A2 mRNA] CTD PMID:19915844 resveratrol multiple interactions ISO RGD:735992 6480464 Resveratrol inhibits the reaction [DMD gene mutant form results in decreased expression of ATP2A2 mRNA] more ... CTD PMID:23297412 more ... resveratrol increases expression EXP 6480464 resveratrol results in increased expression of ATP2A2 protein CTD PMID:25425099 resveratrol increases expression ISO RGD:735992 6480464 resveratrol results in increased expression of ATP2A2 protein CTD PMID:25505154 resveratrol decreases expression ISO RGD:735992 6480464 resveratrol results in decreased expression of ATP2A2 mRNA CTD PMID:22610192 S-butyl-DL-homocysteine (S,R)-sulfoximine decreases expression ISO RGD:735992 6480464 Buthionine Sulfoximine results in decreased expression of ATP2A2 protein CTD PMID:18552690 sarpogrelate affects expression EXP 6480464 sarpogrelate affects the expression of ATP2A2 mRNA, sarpogrelate affects the expression of ATP2A2 protein CTD PMID:18088389 silicon dioxide increases expression ISO RGD:731733 6480464 Silicon Dioxide analog results in increased expression of ATP2A2 mRNA CTD PMID:25895662 simvastatin increases expression EXP 6480464 Simvastatin results in increased expression of ATP2A2 mRNA, Simvastatin results in increased expression of ATP2A2 protein CTD PMID:15916736 sodium arsenate increases expression ISO RGD:735992 6480464 sodium arsenate results in increased expression of ATP2A2 mRNA CTD PMID:21795629 sodium arsenate decreases expression ISO RGD:735992 6480464 sodium arsenate results in decreased expression of ATP2A2 mRNA CTD PMID:30953684 sodium arsenite decreases expression ISO RGD:731733 6480464 sodium arsenite results in decreased expression of ATP2A2 mRNA CTD PMID:28595984 sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of ATP2A2 protein CTD PMID:29459688 sodium chloride decreases expression EXP 6480464 Sodium Chloride results in decreased expression of ATP2A2 mRNA CTD PMID:17325658 sodium chloride multiple interactions EXP 6480464 simendan inhibits the reaction [Sodium Chloride results in decreased expression of ATP2A2 mRNA] CTD PMID:17325658 staurosporine decreases expression EXP 6480464 Staurosporine results in decreased expression of ATP2A2 mRNA CTD PMID:10625299 streptozocin decreases activity EXP 6480464 Streptozocin results in decreased activity of ATP2A2 protein CTD PMID:16685413 streptozocin decreases expression ISO RGD:735992 6480464 Streptozocin results in decreased expression of ATP2A2 mRNA CTD PMID:29935216 streptozocin multiple interactions ISO RGD:735992 6480464 [bisphenol A co-treated with Streptozocin] results in decreased expression of ATP2A2 mRNA more ... CTD PMID:29935216 sulforaphane increases expression ISO RGD:735992 6480464 sulforafan results in increased expression of ATP2A2 mRNA CTD PMID:30529165 sunitinib multiple interactions ISO RGD:735992 6480464 PIK3CA protein inhibits the reaction [Sunitinib results in decreased expression of ATP2A2 protein] CTD PMID:31025080 sunitinib decreases expression ISO RGD:735992 6480464 Sunitinib results in decreased expression of ATP2A2 protein CTD PMID:31025080 tacrolimus hydrate increases expression ISO RGD:735992 6480464 Tacrolimus results in increased expression of ATP2A2 mRNA CTD PMID:25270620 tamoxifen affects expression ISO RGD:735992 6480464 Tamoxifen affects the expression of ATP2A2 mRNA CTD PMID:17555576 tert-butyl hydroperoxide decreases expression ISO RGD:731733 6480464 tert-Butylhydroperoxide results in decreased expression of ATP2A2 mRNA CTD PMID:15336504 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of ATP2A2 mRNA CTD PMID:31150632 tetrachloromethane increases expression ISO RGD:735992 6480464 Carbon Tetrachloride results in increased expression of ATP2A2 mRNA CTD PMID:31919559 tetramethylpyrazine increases expression ISO RGD:731733 6480464 tetramethylpyrazine results in increased expression of ATP2A2 mRNA CTD PMID:15520497 tetraphene decreases expression ISO RGD:735992 6480464 benz(a)anthracene results in decreased expression of ATP2A2 mRNA CTD PMID:26377693 tetraphene multiple interactions ISO RGD:735992 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ATP2A2 mRNA CTD PMID:27858113 thapsigargin affects response to substance ISO RGD:731733 6480464 ATP2A2 protein affects the susceptibility to Thapsigargin CTD PMID:17475205 thapsigargin increases expression EXP 6480464 Thapsigargin results in increased expression of ATP2A2 mRNA CTD PMID:19244478 , PMID:20816668 thapsigargin increases expression ISO RGD:731733 6480464 Thapsigargin results in increased expression of ATP2A2 mRNA CTD PMID:20816668 thapsigargin decreases activity EXP 6480464 Thapsigargin results in decreased activity of ATP2A2 protein CTD PMID:17287366 thapsigargin multiple interactions EXP 6480464 [Thapsigargin results in decreased activity of ATP2A2 protein] which results in decreased transport of Calcium more ... CTD PMID:19244478 titanium dioxide decreases expression ISO RGD:735992 6480464 titanium dioxide results in decreased expression of ATP2A2 mRNA CTD PMID:23557971 titanium dioxide increases expression ISO RGD:735992 6480464 titanium dioxide results in increased expression of ATP2A2 mRNA CTD PMID:31298478 titanium dioxide multiple interactions ISO RGD:735992 6480464 Resveratrol inhibits the reaction [titanium dioxide results in increased expression of ATP2A2 mRNA] CTD PMID:31298478 torcetrapib increases expression ISO RGD:731733 6480464 torcetrapib results in increased expression of ATP2A2 mRNA CTD PMID:23228038 tributylstannane decreases expression ISO RGD:731733 6480464 tributyltin results in decreased expression of ATP2A2 protein CTD PMID:23743301 trichloroacetic acid increases expression EXP 6480464 Trichloroacetic Acid results in increased expression of ATP2A2 mRNA CTD PMID:14565619 trichloroethene decreases expression EXP 6480464 Trichloroethylene results in decreased expression of ATP2A2 mRNA CTD PMID:14565619 more ... trichloroethene decreases expression ISO RGD:731733 6480464 Trichloroethylene results in decreased expression of ATP2A2 mRNA CTD PMID:25847060 triclosan decreases expression ISO RGD:731733 6480464 Triclosan results in decreased expression of ATP2A2 mRNA CTD PMID:30510588 trimellitic anhydride increases expression ISO RGD:735992 6480464 trimellitic anhydride results in increased expression of ATP2A2 mRNA CTD PMID:19042947 tunicamycin increases expression ISO RGD:735992 6480464 Tunicamycin results in increased expression of ATP2A2 mRNA CTD PMID:17127020 tunicamycin increases expression ISO RGD:731733 6480464 Tunicamycin results in increased expression of ATP2A2 mRNA CTD PMID:29453283 valproic acid increases methylation ISO RGD:731733 6480464 Valproic Acid results in increased methylation of ATP2A2 gene CTD PMID:29154799 valproic acid affects expression ISO RGD:731733 6480464 Valproic Acid affects the expression of ATP2A2 mRNA CTD PMID:25979313 valproic acid increases expression ISO RGD:731733 6480464 Valproic Acid results in increased expression of ATP2A2 mRNA CTD PMID:23179753 vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of ATP2A2 mRNA CTD PMID:19015723 vinclozolin decreases expression EXP 6480464 vinclozolin results in decreased expression of ATP2A2 mRNA CTD PMID:15686871 , PMID:23034163 zidovudine multiple interactions ISO RGD:735992 6480464 [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in decreased expression of ATP2A2 mRNA CTD PMID:11706060 zinc oxide decreases expression ISO RGD:731733 6480464 Zinc Oxide analog results in decreased expression of ATP2A2 mRNA CTD PMID:27185063
Gene-Chemical Interaction Annotations
